Raia Drogasil (OTCMKTS:RADLY) Hits New 52-Week Low – Here’s What Happened

Raia Drogasil S.A. (OTCMKTS:RADLY)’s stock price reached a new 52-week low on Tuesday. The stock traded as low as $2.63 and last traded at $2.71, with a volume of 13,437 shares trading hands. The stock had previously closed at $2.76.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 price objective on the stock in a report on Sunday, October 18th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $5.20.

Raia Drogasil Stock Performance

The company has a market capitalization of $3.57 billion and a price-to-earnings ratio of 18.10. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99. The stock’s fifty day simple moving average is $3.68 and its 200-day simple moving average is $4.05.

Raia Drogasil (OTCMKTS:RADLY) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The business had revenue of $2.22 billion during the quarter, compared to the consensus estimate of $2.43 billion. Raia Drogasil had a net margin of 2.89% and a return on equity of 20.61%. Analysts predict that Raia Drogasil S.A. will post 0.17 EPS for the current year.

About Raia Drogasil

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.